In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $16.62 in the prior trading day, Alx Oncology Holdings Inc (NASDAQ: ALXO) closed at $15.36, down -7.58%. In other words, the price has decreased by -$7.58 from its previous closing price. On the day, 1.28 million shares were traded. ALXO stock price reached its highest trading level at $17.13 during the session, while it also had its lowest trading level at $15.2144.
Ratios:
Our goal is to gain a better understanding of ALXO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.24 and its Current Ratio is at 5.24. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 08, 2024, Downgraded its rating to Hold and sets its target price to $14 from $10 previously.
On December 08, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $18.
Jefferies Downgraded its Buy to Hold on December 22, 2021, whereas the target price for the stock was revised from $65 to $25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 16 ’24 when Pons Jaume sold 50,000 shares for $14.20 per share. The transaction valued at 710,195 led to the insider holds 604,205 shares of the business.
Pons Jaume sold 20,000 shares of ALXO for $223,036 on Apr 04 ’24. The PRESIDENT & CSO now owns 628,359 shares after completing the transaction at $11.15 per share. On Mar 14 ’24, another insider, Lettmann Jason, who serves as the CHIEF EXECUTIVE OFFICER of the company, bought 4,400 shares for $11.31 each. As a result, the insider paid 49,771 and bolstered with 171,620 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 775661568 and an Enterprise Value of 604796992.
Stock Price History:
Over the past 52 weeks, ALXO has reached a high of $17.47, while it has fallen to a 52-week low of $3.94. The 50-Day Moving Average of the stock is 11.35%, while the 200-Day Moving Average is calculated to be 48.96%.
Shares Statistics:
The stock has traded on average 494.84K shares per day over the past 3-months and 462730 shares per day over the last 10 days, according to various share statistics. A total of 49.95M shares are outstanding, with a floating share count of 27.58M. Insiders hold about 45.39% of the company’s shares, while institutions hold 57.41% stake in the company. Shares short for ALXO as of 1713139200 were 3694845 with a Short Ratio of 7.47, compared to 1710460800 on 2913735. Therefore, it implies a Short% of Shares Outstanding of 3694845 and a Short% of Float of 13.11.
